Boston Scientific announced today that it received CE mark for its navigation-enabled Farawave Nav ablation catheter and Faraview software. Farawave Nav and the Faraview software make up part of the company’s Farapulse pulsed field ablation (PFA) system. Boston Scientific initially won FDA approval for Farapulse in January 2024. In doing so, it became second company […]
Boston Scientific
Medtronic, Boston Scientific settle Axonics IP dispute
Medtronic and Axonics — now part of Boston Scientific — have confidentially settled their long-running IP dispute. Legal news sites, including Bloomberg Law, were the first to break the news this week. A Medtronic spokesperson provided the following statement to MassDevice today: “Medtronic and Boston Scientific are pleased to have reached a confidential settlement agreement that will resolve […]
Boston Scientific expects double-digit sales growth in 2025 following Street-beating Q4
Boston Scientific shares were up this morning on fourth-quarter results that beat the consensus forecast on Wall Street. Shares of BSX rose more than 2% to $105.77 apiece in morning trading today. The Marlborough, Massachusetts–based medtech company reported profits of $566 million. That equals 38¢ per share on sales of $4.56 billion for the three […]
Boston Scientific data supports Farapulse, Watchman FLX
Boston Scientific today reported data from separate studies backing its Farapulse and Watchman FLX systems. The data comes just days after CEO Mike Mahoney singled out the two platforms as key growth drivers for the company moving forward. Speaking at the JP Morgan Healthcare Conference, Mahoney talked about how they could spur growth — including […]
Boston Scientific expects Farapulse, Watchman to drive 2025 growth
Boston Scientific CEO Mike Mahoney expects more growth for the company in 2025. Speaking at the JP Morgan Healthcare Conference in San Francisco, Mahoney outlined the company’s plans, including a couple of products he expects to significantly drive that planned growth. The plans echoed the sentiment from the company’s September 2023 Investor Day event. “We […]
Johnson & Johnson MedTech halts Varipulse PFA cases due to stroke reports
Johnson & Johnson MedTech announced today that it “temporarily paused” all U.S. cases using its Varipulse pulsed field ablation (PFA) system as of Jan. 5. “Out of an abundance of caution, Johnson & Johnson MedTech temporarily paused the U.S. External Evaluation and all U.S. Varipulse cases while we investigate the root cause of four reported […]
Boston Scientific makes IVL play with Bolt Medical acquisition
Boston Scientific announced today that it agreed to acquire intravascular lithotripsy (IVL) platform developer Bolt Medical. On a 100% basis — before considering an existing equity stake and other adjustments — the deal is valued at $600 million upfront with up to an additional $300 million upon achievement of certain regulatory milestones. The acquisition marks […]
The top medtech stories of 2024
AFib-treating cardiac ablation, surgical robotics, nitinol and diabetes treatment tech lead among this year’s top medtech stories. Meanwhile, medical device companies have been seeking more tuck-in M&A — and continuing to refocus and boost operational efficiency — to better prepare for whatever the future brings. Here are the top medtech stories that caught the attention […]
The biggest medtech M&A moves of 2024
In 2024, we saw another proactive year for some of the biggest names in medtech as they looked to bolster their ranks through acquisitions. Over the course of the year, the number of billion-dollar sales deals continued to climb, with some companies involved more than once. Analysts even suggested that, in 2025, there could be […]
Boston Scientific updates instructions for cryoablation catheters after reported deaths
The FDA issued a notice alerting customers to updates made by Boston Scientific to its PolarX cryoablation catheters. This recall involves updating instructions for use (IFU), not removing devices from the market. The FDA identified it as the most serious type of recall, though, as it may cause serious injury or death. Boston Scientific updated […]
Boston Scientific warns on potential need to replace Accolade pacemaker devices early
The FDA today issued an alert after Boston Scientific warned of the potential need for the early replacement of certain pacemaker devices. This month, Boston Scientific issued a notice to customers saying that it identified issues with a subpopulation of Accolade, Proponent, Essentio and Altrua 2 dual-chamber standard life and dual-chamber extended life pacemakers and […]
